Abstract
The serine protease complement factor B (Bf), an acute phase plasma protein, is a component of the alternative pathway of complement activation. Previous studies revealed that several cytokines including IFN-γ and IL-1 are involved in mediating acute phase Bf expression. To determine the molecular details of Bf expression we isolated, sequenced and characterized the 5′ flanking regions of the human and murine Bf genes. In both species the Bf transcriptional start site in liver was located <400 by 3′ to the polyadenylation site of the upstream C2 gene. This upstream intergenic region contained >65% nucleotide homology between species. Within this region, an IRS and three heat shock consensus elements were found in the murine sequence in an identical position to that of the human. To examine the functional details of Bf expression, a series of mouse and human Bf promoter - chloramphenicol acetyltransferase (CAT) chimeric gene constructs were transfected into mouse L or human HepG2 cells. Analysis of expression of these fusion gene constructs revealed that 1) cis-acting DNA sequences identified, at least in part, in the 3′ untranslated region of the C2 gene (within the 400 by upstream of the Bf cap site) mediate responsiveness to IL-1 and IFN-γ, 2) the responsiveness to each mediator appears to be conferred by separate upstream regions similar in position and homologous in man and mouse, and 3) the IL-1 responsive region in both species appears to have the characteristics of an enhancer element. The results of this analysis suggest a selective pressure to conserve the intergenic sequence between C2 and Bf genes and that further studies of these sequences will be useful in elucidating mechanisms controlling the acute phase response.
Similar content being viewed by others
References
Gitlin JD, Colten HR: Molecular biology of the acute phase plasma proteins. Lymphokines 14: 123–153, 1988
Chaplin DD, Woods DE, Whitehead AS, Goldberger G, Colten HR, Seidman G: Molecular map of the murine S region. Proc. Natl. Acad. Sci. USA 80: 6947–6951, 1983
Carroll MC, Campbell RD, Bentley DR, Porter RR: A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature 307: 237–241, 1984
Perlmutter DH, Colten HR, Grossberger D, Strominger J, Seidman G, Chaplin DD: Expression of complement protein C2 and factor B in transfected L cells. J. Clin. Invest. 76: 1449–1454, 1985
Ramadori G, Sipe JD, Dinarello CA, Mizel SB, Colten HR: Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin-1 (IL-1) and purified human IL-1. J. Exp. Med. 162: 930–942, 1985
Perlmutter DH, Dinarello CA, Punsal PI, Colten HR: Cachectin/tumor necrosis factor regulates hepatic acute phase gene expression. J. Clin. Invest. 78: 1349–1354, 1986
Perlmutter DH, Goldberger G, Dinarello CA, Mizel SB, Colten HR: Regulation of class III major histocompatibility complex gene products by interleukin-1. Science 232: 850–852, 1986
Strunk RC, Cole FS, Perlmutter DH, Colten HR: γ-interferon increases expression of class III complement genes C2 and factor B in human monocytes and in murine fibroblasts transfected with human C2 and factor B genes. J. Biol. Chem. 260: 15280–15285, 1985
Wu L, Morley BJ, Campbell RD: Cell-specific expression of human complement protein factor B gene: Evidence for the role of two distinct 5′-flanking elements. Cell 48: 331–342, 1987
Woods DE, Markham AF, Ricker AT, Goldberger G, Colten HR: Isolation of cDNA clones for the human complement protein factor B, a class III major histocompatibility complex gene product. Proc. Natl. Acad. Sci. USA 79: 5661–5665, 1982
Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74: 5463–5467, 1977
Enquist LW, Vandewoude GF, Wagner M, Smiley JR, Summers WC: Gene 7: 335–342, 1979
Gorman CM, Moffat LF, Howard BH: Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cell. Mol. Cell. Biol. 2: 1044–1051, 1982
Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294–5299, 1979
Walker MD, Edlund T, Boulet AM, Rutter WJ: Cell-specific expression controlled by the 5′-flanking region of insulin and chymotrypsin genes. Nature 306: 557–561, 1983
Morley BJ, Campbell RD: Internal homologies of the Ba fragment from human complement component factor B, a class III MHC antigen. EMBO J. 3: 153–157, 1984
Laimins LA, Khoury G, Gorman CM, Howard BH, Gross P: Host-specific activation of transcription by tandem repeats from simian virus 40 and Moloney murine sarcoma virus. Proc. Natl. Acad. Sci. USA 79: 6453–6457, 1982
Katz Y, Cole FS, Strunk RC: Synergism between γ-interferon and lipopolysaccharide for synthesis of factor B, but not C2, in human fibroblast. J. Exp. Med. 167: 1–14, 1988
Ramadori G, Sipe JD, Colten HR: Expression and regulation of the murine serum amyloid A (SAA) gene in extrahepatic sites. J. Immunol. 135: 3645–3647, 1985
Lee SH, Starkey PM, Gordon S: Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4/80. J. Exp. Med. 161: 475–489, 1985
Friedman RL, Stark GR: Alpha-interferon-ιnduced transcription of HLA and metallothionein genes containing homologous upstream sequences. Nature 314: 637–639, 1985
Israel A, Kimura A, Fournier A, Fellous M, Kourilsky P: Interferon response sequence potentiates activity of an enhancer in the promoter region of a mouse H-2 gene. Nature 322: 743–746, 1986
Besta PV, Sherman PA, Ting JP-Y: Identification of an interferon-γ response region 5′ of the human histocompatibility leukocyte antigen DRα chain gene which is active in human glioblastoma multiforme lines. J. Immunol. 138: 1275–1280, 1987
Dorn A, Durand B, Matting C, LeMeur M, Benoist C, Mathis D: Conserved major histocompatibility complex class II boxes — X and Y — are transcriptional control elements and specifically bind nuclear proteins. Proc. Natl. Acad. Sci. USA 84: 6209–6253, 1987
Benech P, Vigneron M, Paretz D, Revel M, Chebath J: Interferon-responsive regulatory elements in the promoter of the human 2′, 5′-oligo(A) synthetase gene. Mol. Cell. Biol. 7: 4498–4504, 1987
Blanar MA, Boettger EC, Flavell RA: Transcriptional activation of HLA-DR alpha by interferon gamma requires a transacting protein. Proc. Natl. Acad. Sci. USA 85: 4672–4676, 1988
Karin M, Haslinger A, Heguy A, Deitlin T, Cooke T: The metal responsive elements act as positive modulators of human metallothionein-IIA enhancer activity. Mol. Cell. Biol. 7: 606–613, 1987
Fujita T, Ohno S, Yasumitsu H, Taniguchi T: Delimitation and properties of DNA sequences required for the regulated expression of human interferon-β gene. Cell 41: 489–496, 1985
Chandler VL, Maler BA, Yamamoto KR: DNA sequences bound specifically by glucocorticoid receptor in vitro render heterologous promoter hormone responsive in vivo. Cell 33: 489–499, 1983
Angel P, Baumann I, Stein B, Delins H, Rahmsdorf HJ, Herrlich P: 12–0-tetradecanoyl-phorbol-13-acetate (TPA) induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol. Cell. Biol. 7: 2256–2266, 1987
Pelham HRB, Bienz M: A synthetic heat-shock promoter element confers heat-inducibility on the herpes simplex virus thymidine kinase gene. EMBO J. 1: 1473–1477, 1982
Kozak M: Point mutations define a sequence flanking the AVG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44: 283–292, 1986
Gross-Bellard M, Oudd P, Chambon P: Isolation of high-molecular weight DNA from mammalian cells. Eur. J. Biochem. 36: 32–38, 1973
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nonaka, M., Gitlin, J.D. & Colten, H.R. Regulation of human and murine complement: Comparison of 5′ structural and functional elements regulating human and murine complement factor B gene expression. Mol Cell Biochem 89, 1–14 (1989). https://doi.org/10.1007/BF00228274
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00228274